Paper36928900
Calprotectin as new potential clinical marker for multiple myeloma.
Khosravi P and 4 others. PLoS One, 2023. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Calprotectin as new potential clinical marker for multiple myeloma. Papers, record 36928900. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36928900
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukocyte L1 Antigen Complex | Major topic |
| Multiple Myeloma | Major topic |
| Humans | |
| Biomarkers | |
| Case-Control Studies | |
| Enzyme-Linked Immunosorbent Assay | |
| Feces | |
| Inflammation | |
| Iran |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20368797 | S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function. | J Biomed Biotechnol | 2010 | https://conductscience.org/library/papers/20368797 | PubMed |
| 2 | 28573847 | Nickel Sequestration by the Host-Defense Protein Human Calprotectin. | J Am Chem Soc | 2017 | https://conductscience.org/library/papers/28573847 | PubMed |
| 3 | 31148601 | Increased fecal primary bile acids in multiple myeloma with engraftment syndrome diarrhea after stem cell transplant. | Bone Marrow Transplant | 2019 | https://conductscience.org/library/papers/31148601 | PubMed |
| 4 | 32181154 | Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time? | Front Oncol | 2020 | https://conductscience.org/library/papers/32181154 | PubMed |
| 5 | 27818100 | The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins. | Structure | 2016 | https://conductscience.org/library/papers/27818100 | PubMed |
| 6 | 31088326 | Clinical value of fecal calprotectin. | Crit Rev Clin Lab Sci | 2019 | https://conductscience.org/library/papers/31088326 | PubMed |
| 7 | 16617319 | Toll-like receptors mediate proliferation and survival of multiple myeloma cells. | Leukemia | 2006 | https://conductscience.org/library/papers/16617319 | PubMed |
| 8 | 33756018 | Faecal calprotectin in children with multisystem inflammatory syndrome: A pilot case-control study. | Acta Paediatr | 2021 | https://conductscience.org/library/papers/33756018 | PubMed |
| 9 | 16721383 | Inflammation and multiple myeloma: the Toll connection. | Leukemia | 2006 | https://conductscience.org/library/papers/16721383 | PubMed |
| 10 | 30671025 | Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma. | Front Endocrinol (Lausanne) | 2018 | https://conductscience.org/library/papers/30671025 | PubMed |
| 11 | 30726887 | Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases. | J Crohns Colitis | 2019 | https://conductscience.org/library/papers/30726887 | PubMed |
| 12 | 30342711 | Fecal Calprotectin. | Adv Clin Chem | 2018 | https://conductscience.org/library/papers/30342711 | PubMed |
| 13 | 11511563 | Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. | Gut | 2001 | https://conductscience.org/library/papers/11511563 | PubMed |
| 14 | 30197475 | From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. | World J Gastroenterol | 2018 | https://conductscience.org/library/papers/30197475 | PubMed |
| 15 | 24803811 | Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24803811 | PubMed |
| 16 | 29656372 | Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein. | Clin Rheumatol | 2018 | https://conductscience.org/library/papers/29656372 | PubMed |
| 17 | 34261042 | Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients. | Endocr Connect | 2021 | https://conductscience.org/library/papers/34261042 | PubMed |
| 18 | 32818491 | Calprotectin in inflammatory bowel disease. | Clin Chim Acta | 2020 | https://conductscience.org/library/papers/32818491 | PubMed |
| 19 | 30083975 | Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer. | Inflamm Res | 2018 | https://conductscience.org/library/papers/30083975 | PubMed |
| 20 | 19451397 | The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. | J Leukoc Biol | 2009 | https://conductscience.org/library/papers/19451397 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40520870 | A short-term prognostic model based on urinary IgG, CO2CP and TP for newly diagnosed multiple myeloma. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/40520870 | PubMed |
| 38426298 | Do Alarmins Have a Role in Multiple Myeloma? | Turk J Haematol | 2024 | https://conductscience.org/library/papers/38426298 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36928900
GET https://conductscience.org/api/papers/v1/36928900/references?page=2